SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-05-28
👔
Immunocore Holdings plc
@IMCR_InsiderForm 4 Filing: Bell John Irving Acquires (Grant) shares of $IMCR
STOCK AWARD / GRANT
⚡ MATERIALITY: 1/10
corporate issuer
Immunocore Holdings plc
Ticker: $IMCR
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-05-27
Shares: 27,492
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Bell John Irving, holds the title of Director at Immunocore Holdings plc.
On 2026-05-27, the insider transacted 27,492 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Bell John Irving (Director) was granted $0 of $IMCR
Post-Transaction Position: 27,492 shares
SEC Accession No: 0001969932-26-000002 (CIK: 1969932)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.